vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...
Medscape1mon
Short-Course, Low-Dose Oral Betamethasone as an Adjunct in the Treatment of Acute Infective Sinusitis
Objective: To assess the effect of a short course of low-dose oral corticosteroid used as an adjunct to antimicrobials in patients with acute infective sinusitis. Study Design and Patients ...
Nasdaq15d
vTv Therapeutics Announces Resumption of CATT1 Phase 3 Trial for Cadisegliatin as Potential First Oral Adjunct Therapy for Type 1 Diabetes
vTv Therapeutics resumes CATT1 Phase 3 trial for cadisegliatin, an oral adjunct therapy for type 1 diabetes, after FDA lifts hold. vTv Therapeutics announced that the FDA has lifted the clinical ...